The present study (Table 1) together with the studies published by Bekers et al. (2019) and Sunitsch et al. (2019) showed that approximately 23% of myxomas with GNAS pathogenic variants carried variants in other locations other than the “hotspot” variants p.R201C and p.R201H. This evidence concerns the gene GNAS and myxoma.